Skip to ContentSkip to Navigation
Practical matters How to find us dr. A.N. (Angelique) Voorberg


Hand eczema: from pathogenesis to novel treatments

Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab: a cross-sectional study from the BioDay registry

Efficacy and safety of oral alitretinoin versus oral azathioprine in patients with severe chronic hand eczema: Results from a prematurely discontinued randomized controlled trial

Guidelines for diagnosis, prevention and treatment of hand eczema

Identification of Risk Factors for Dupilumab-associated OculaSurface Disease in Patients with Atopic Dermatitis

Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study

The long-term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis: 52 week results from the Dutch BioDay Registry

Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry

Prevalence of adult atopic dermatitis in the general population, with a focus on moderate-to-severe disease: results from the Lifelines Cohort Study

Vesicular hand eczema transcriptome analysis provides insights into its pathophysiology

Read more